Displaying items by tag: neuroscience

The study, utilizing the relatively new field of metagenomics, demonstrated an imbalance in the gut microbiome of patients with Parkinson’s disease.
Michael Ho is the first in UAB’s history to be awarded this prestigious scholarship by AED in recognition of his scholastic achievements in academics as well as extracurriculars.
The AHEAD study is looking to recruit people at risk for developing Alzheimer’s disease for a new study.
An internationally recognized clinician and researcher in Parkinson’s disease, UAB’s David Standaert, M.D., Ph.D., has been honored with a lifetime achievement award from the Parkinson’s Association of Alabama.
The New Innovator awards support investigators in the early stages of their careers.
The study will examine a protein that may help slow bleeding in the brain when given within a two-hour window following the first signs of hemorrhage.
Carbohydrates are directly linked to the development of Type 2 diabetes, but a higher-carb diet is underused in research models.
The new technique to predict seizure clusters could, if confirmed, have a profound impact on patients with drug-resistant epilepsy who are prone to seizure clusters. 
An aneurysm is a bulge in a blood vessel caused by a weakness in the blood vessel wall, resulting in an increase of pressure in a small area and causing the vessel to balloon.
Medical professionals are calling on the World Health Assembly to pass a resolution calling for folic acid fortification in staple foods to prevent spina bifida worldwide.
Radiofrequency ablation precisely delivers heat energy that can destroy lesions within the brain that are the cause of seizures.
With the number of Americans with dementia expected to increase dramatically, UAB’s new brain health clinics point the way to improving brain health over a lifespan.
The distinct cell populations were identified by single-nucleus RNA sequencing of 21,600 cells of the rat ventral tegmental area, located in the midbrain.
The investigational drug masitinib appears to inhibit parts of the immune system that may be overactive in ALS.
Page 1 of 13